Effect of exercise on ovarian morphology and expression of nerve growth factor and α1-and β2-adrenergic receptors in rats with steroid-induced polycystic ovaries

Journal of Neuroendocrinology

Volumn 17, Issue 12, 2005, Pages 846-858

  Manni, L ^a,b   Cajander, S ^c   Lundeberg, T ^d   Naylor, A S ^e   Aloe, L ^b   Holmang A ^a   Jonsdottir, I H ^e,f   Stener Victorin, Elisabet ^a,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CNR   (Italy)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Institute of Laboratory Medicine   (Sweden)

Author keywords

Adrenergic receptors; Morphology; Neurotrophin receptors; NGF; Physical exercise; Polycystic ovaries; Sympathetic nervous system

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYMPATHETIC INNERVATION; TRANSCRIPTION REGULATION;

ANIMALS; BODY WEIGHT; ESTRADIOL; EXERTION; FEMALE; NERVE GROWTH FACTOR; ORGAN SIZE; OVARY; POLYCYSTIC OVARY SYNDROME; RATS; RATS, INBRED WKY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM;

EID: 28044460291     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2005.01378.x     Document Type: Article

References (60)

1. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004; 60: 1-17.
2. Semenova I. Adrenergic innervation of the ovaries in Stein-Leventhal syndrome. Vestn Akad Med Nauk SSSR 1969; 24: 58-62.
3. Heider U, Pedal I, Spanel-Borowski K. Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil Steril 2001; 75: 1141-1147.
4. Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod 1986; 35: 647-655.
5. Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 1993; 133: 2696-2703.
6. Dissen GA, Lara HE, Leyton V, Paredes A, Hill DF, Costa ME, Martines-Sarrano A, Ojeda SR. Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology 2000; 141: 1073-1082.
7. Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993; 133: 2690-2695.
8. Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Ojeda SR. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 2000; 141: 1059-1072.
9. Stener-Victorin E, Lundeberg T, Waldenstrom U, Manni L, Aloe L, Gunnarsson S, Janson PO. Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol Reprod 2000; 63: 1497-1503.
10. Stener-Victorin E, Lundeberg T, Waldenstrom U, Bileviciute-Ljungar I, Janson PO. Effects of electro-acupuncture on corticotropin-releasing factor in rats with experimentally-induced polycystic ovaries. Neuropeptides 2001; 35: 227-231.
11. Stener-Victorin E, Lundeberg T, Cajander S, Aloe L, Manni L, Waldenstrom U, Janson PO. Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod Biol Endocrinol 2003; 1: 33.
12. Stener-Victorin E, Kobayashi R, Watanabe O, Lundeberg T, Kurosawa M. Effect of electro-acupuncture stimulation of different frequencies and intensities on ovarian blood flow in anaesthetised rats with steroid-induced polycystic ovaries. Reprod Biol Endocrinol 2004; 2: 16.
13. Stener-Victorin E, Ploj K, Larsson B-M, Holmäng A. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol 2005; 3: 44.
14. Manni L, Antonelli A, Costa N, Aloe L. Stress alters vascular-endothelial growth factor expression in rat arteries: Role of nerve growth factor. Basic Res Cardiol 2005; 100: 121-130.
15. Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O'Callaghan C, Czupryniak L, Hillhouse EW, Prelevic GM. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 4496-4501.
16. Lambert GW, Jonsdottir IH. Influence of voluntary exercise on hypothalamic norepinephrine. J Appl Physiol 1998; 85: 962-966.
17. Kramer JM, Plowey ED, Beatty JA, Little HR, Waldrop TG. Hypothalamus, hypertension, and exercise. Brain Res Bull 2000; 53: 77-85.
18. Niklasson M, Daneryd P, Lonnroth P, Holmang A. Effects of exercise on insulin distribution and action in testosterone-treated oophorectomized female rats. J Appl Physiol 2000; 88: 2116-2122.
19. Droste SK, Gesing A, Ulbricht S, Muller MB, Linthorst AC, Reul JM. Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary-adrenocortical axis. Endocrinology 2003; 144: 3012-3023.
20. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000; 80: 1055-1081.
21. Jonsdottir I. Neuropeptides and their interaction with exercise and immune function. Immunol Cell Biol 2000; 78: 562-570.
22. Persson AI, Naylor AS, Jonsdottir IH, Nyberg F, Eriksson PS, Thorlin T. Differential regulation of hippocampal progenitor proliferation by opioid receptor antagonists in running and non-running spontaneously hypertensive rats. Eur J Neurosci 2004; 19: 1847-1855.
23. Shyu BC, Andersson SA, Thoren P. Spontaneous running in wheels. A microprocessor assisted method for measuring physiological parameters during exercise in rodents. Acta Physiol Scand 1984; 121: 103-109.
24. Jonsdottir IH, Asea A, Hoffmann P, Hellstrand K, Thoren P. Natural immunity and chronic exercise in rats. The involvement of the spleen and the splenic nerves. Life Sci 1996; 58: 2137-2146.
25. Tirassa P, Manni L, Stenfors C, Lundeberg T, Aloe L. RT-PCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues. J Biotechnol 2000; 84: 259-272.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroforin extraction. Anal Biochem 1987; 162: 156-159.
27. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci USA 1969; 64: 787-794.
28. Wescamp, G, Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J Neurochem 1987; 48: 1779-1786.
29. Tirassa P, Stenfors C, Lundeberg T, Aloe L. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCKA and CCKB receptors. Br J Pharmacol 1998; 123: 1230-1236.
30. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med 1987; 316: 1309-1315.
31. Duclos M, Corcuff JB, Pehourcq F, Tabarin A. Decreased pituitary sensitivity to glucocorticoids in endurance-trained men. Eur J Endocrinol 2001; 144: 363-368.
32. Jennings G, Nelson L, Nestel P, Esler M, Korner P, Burton D, Bazelmans J. The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986; 73: 30-40.
33. Nelson L, Jennings GL, Ester MD, Korner PI. Effect of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet 1986; 2: 473-476.
34. Winder WW, Hagberg JM, Hickson RC, Ehsani AA, McLane JA. Time course of sympathoadrenal adaptation to endurance exercise training in man. J Appl Physiol 1978; 45: 370-374.
35. Duncan JJ, Farr JE, Upton SJ, Hagan RD, Oglesby ME, Blair SN. The effects of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA 1985; 254: 2609-2613.
36. Meredith IT, Jennings GL, Esler MD, Dewar EM, Bruce AM, Fazio VA, Korner PI. Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 1990; 8: 859-866.
37. Gielen S, Schuler G, Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation 2001; 103: E1-E6.
38. Paredes A, Galvez A, Leyton V, Aravena G, Fiedler JL, Bustamante D, Lara HE. Stress promotes development of ovarian cysts in rats: the possible role of sympathetic nerve activation. Endocrine 1998; 8: 309-315.
39. Dorfman M, Arancibia S, Fiedler JL, Lara HE. Chronic intermittent cold stress activates ovarian sympathetic nerves and modifies ovarian follicular development in the rat. Biol Reprod 2003; 68: 2038-2043.
40. Andersson S, Lundeberg T. Acupuncture - from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 1995; 45: 271-281.
41. Lara HE, Dorfman M, Venegas M, Luza SM, Luna SL, Mayerhofer A, Guimaraes MA, Rosa E Silva AA, Ramirez VD. Changes in sympathetic nerve activity of the mammalian ovary during a normal oestrous cycle and in polycystic ovary syndrome: Studies in norepinephrine release. Microsc Res Tech 2002; 59: 495-502.
42. Lara HE, McDonald JK, Ojeda SR. Involvement of nerve growth factor in female sexual development. Endocrinology 1990; 126: 364-375.
43. Lobo RA, Granger LR, Paul WL, Goebelsmann U, Mishell DR Jr. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol 1983; 145: 496-503.
44. Lobo RA. The role of neurotransmitters and opioids in polycystic ovarian syndrome. Endocrinol Metab Clin North Am 1988; 17: 667-683.
45. Shoupe D, Lobo RA. Evidence for altered catecholamine metabolism in polycystic ovary syndrome. Am J Obstet Gynecol 1984; 150: 566-571.
46. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome, wedge resection revisited in the age of laparoscopy. Fertil Steril 1995; 63: 439-463.
47. Balen AH, Jacobs HS. A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil Steril 1994; 62: 921-925.
48. Rickenlund A, Carlstrom K, Ekblom B, Brismar TB, von Schoultz B, Hirschberg AL. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril 2003; 79: 947-955.
49. Rush RA, Chie E, Liu D, Tafreshi A, Zettler C, Zhou XF. Neurotrophic factors are required by mature sympathetic neurons for survival, transmission and connectivity. Clin Exp Pharmacol Physiol 1997; 24: 549-555.
50. Ang ET, Wong PT, Moochhala S, Ng YK. Neuroprotection associated with running: is it a result of increased endogenous neurotrophic factors? Neuroscience 2003; 118: 335-345.
51. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49-56.
52. Matsuda H, Koyama H, Oikawa M, Yoshihara T, Kaneko M. Nerve growth factor-like activity detected in equine peripheral blood after running exercise. Zentralbl Veterinarmed A 1991; 38: 557-559.
53. Samina Riaz S, Tomlinson DR. Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta-adrenoceptor agonists. Brain Res Mol Brain Res 2000; 85: 179-188.
54. Culmsee C, Stumm RK, Schafer MK, Weihe E, Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 1999; 379: 33-45.
55. Dissen GA, Hirshfield AN, Malamed S, Ojeda SR. Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis. Endocrinology 1995; 136: 4681-4692.
56. Dissen GA, Mayerhofer A, Ojeda SR. Participation of nerve growth factor in the regulation of ovarian function. Zygote 1996; 4: 309-312.
57. Miller FD, Speelman A, Mathew TC, Fabian J, Chang E, Pozniak C, Toma JG. Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons. Dev Biol 1994; 161: 206-217.
58. Civantos Calzada B, Aleixandre de Artinano A. Alpha-adrenoceptor subtypes. Pharmacol Res 2001; 44: 195-208.
59. Wasilewska-Dziubinska E, Borowiec M, Chmielowska M, Wolinska-Witort E, Baranowska B. Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells. Neuro Endocrinol Lett 2002; 23: 141-148.
60. Aguado LI, Petrovic SL, Ojeda SR. Ovarian beta-adrenergic receptors during the onset of puberty: characterization, distribution, and coupling to steroidogenic responses. Endocrinology 1982; 110: 1124-1132.